Johnson & Johnson delays vaccine rollout in Europe amid blood clots probe in US
Published
Johnson & Johnson has said it is delaying the rollout of its coronavirus vaccine in Europe amid a US probe into rare blood clots.
Full ArticlePublished
Johnson & Johnson has said it is delaying the rollout of its coronavirus vaccine in Europe amid a US probe into rare blood clots.
Full ArticleFollowing rare blood clots, the company says it will also delay the vaccine rollout in Europe.